FDA pilot offers generative AI medical devices a path to patients before they are authorized

FDA accepts Cadence and Limbic AI medical devices into TEMPO pilot for pre-authorization release

The FDA has accepted AI products from Cadence and Limbic, along with two other devices, into its TEMPO pilot program, which will allow these digital health companies to release their products to patients before receiving full marketing authorization.